Loss of H3K27 trimethylation by immunohistochemistry is frequent in oligodendroglioma, IDH-mutant and 1p/19q-codeleted, but is neither a sensitive nor a specific marker

dc.contributor.author	Pekmezci, M.
dc.contributor.author	Phillips, J.J.
dc.contributor.author	Dirilenoglu, F.
dc.contributor.author	Atasever-Rezanko, T.
dc.contributor.author	Tihan, T.
dc.contributor.author	Solomon, D.
dc.contributor.author	Bollen, A.
dc.contributor.author	Perry, A.
dc.date.accessioned	2021-12-21T08:40:47Z
dc.date.available	2021-12-21T08:40:47Z
dc.date.issued	2020
dc.identifier.issn	16322
dc.identifier.uri	https://doi.org/10.1007/s00401-019-02123-8
dc.identifier.uri	http://dspace.yeniyuzyil.edu.tr:8080/xmlui/handle/20.500.12629/1191
dc.description.abstract	[No abstract available]
dc.description.sponsorship	This study was funded in part by the UCSF Department of Pathology?(M.P.), NIH/NCI U01 (CA229345, J.J.P.) and NIH Director?s Early Independence Award (DP5 OD021403, D.A.S.).
dc.language.iso	English
dc.publisher	Springer
dc.title	Loss of H3K27 trimethylation by immunohistochemistry is frequent in oligodendroglioma, IDH-mutant and 1p/19q-codeleted, but is neither a sensitive nor a specific marker
dc.type	Letter
dc.relation.journal	Acta Neuropathologica
dc.identifier.issue	3
dc.identifier.startpage	597
dc.identifier.endpage	600
dc.identifier.volume	139
dc.identifier.doi	10.1007/s00401-019-02123-8
dc.relation.issue	3
dc.relation.volume	139